Related Experiment Video

Updated: May 27, 2026

Midface Hypoplasia and Cranial Base Morphology in Syndromic Craniosynostosis: A Comparative Analysis Study Using a Predictive Regression Model
08:03

Midface Hypoplasia and Cranial Base Morphology in Syndromic Craniosynostosis: A Comparative Analysis Study Using a Predictive Regression Model

Published on: November 4, 2025

Idiopathic short stature: decision making in growth hormone use

Nidhi Maheshwari1, Naveen K Uli, Sumana Narasimhan

  • 1Division of Pediatric Endocrinology and Diabetes, The Center for Child Health and Policy, Department of Pediatrics, Rainbow Babies and Children's Hospital, Case Western Reserve University, 11100 Euclid Avenue, Room 737, Cleveland, OH 44106, USA.

Indian Journal of Pediatrics
|November 19, 2011
PubMed

Insights

Growth hormone (GH) therapy for idiopathic short stature (ISS) involves complex decisions. Factors beyond growth characteristics influence whether children receive this treatment, highlighting current controversies.

Area of Science:

  • Pediatric Endocrinology
  • Growth Hormone Therapy
  • Idiopathic Short Stature

Background:

  • Short stature is a frequent pediatric concern.
  • Significant controversies exist regarding growth hormone (GH) therapy for idiopathic short stature (ISS), including criteria, cost, medical necessity, and outcomes.
  • Multiple stakeholders, including physicians, families, and payers, make critical decisions influencing GH treatment access.

Purpose of the Study:

  • To examine current ambiguities and controversies surrounding GH therapy for ISS.
  • To identify the key decision-makers involved in prescribing and accessing GH therapy.
  • To explore the non-physiological factors influencing these crucial decisions.

Main Methods:

  • Review of existing literature on GH therapy for ISS.
  • Analysis of decision-making processes by primary care physicians, pediatric endocrinologists, families, and third-party payers.
  • Exploration of factors influencing stakeholder decisions beyond clinical growth parameters.

Main Results:

  • GH therapy decisions for ISS are complex and influenced by multiple factors.
  • Non-physiological elements significantly impact whether short children receive GH treatment.
  • Ambiguities in criteria, cost concerns, and payer policies create barriers to treatment.

Conclusions:

  • The decision-making process for GH therapy in ISS is multifaceted.
  • Understanding stakeholder influences and non-clinical factors is crucial for equitable access.
  • Addressing current controversies may improve treatment guidelines and patient outcomes.

More Related Videos

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts07:56

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts

Published on: January 29, 2018

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...